Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Brii Biosciences-B (02137.HK) repurchased 54,000 shares for HK$52,100 on October 29.
29/10/2026
Zhitong Finance APP News, Brii Biosciences-B (02137.HK) announced that on October 29, 2026, it spent HK$52,100 to repurchase 54,000 shares.
Latest
3 m ago
Xuji Electric (000400.SZ) released its performance for the first three quarters, with net profit attributable to the parent company of 601 million yuan, a year-on-year decrease of 33.35%.
4 m ago
Texas Data Center Construction Boom Hits the Brakes! Governor Tightens Approvals Under Election Pressure, Forcing Developers to Seek Alternatives
4 m ago
Riyue Heavy Industry (603218.SH) released its first three quarters performance, with net profit attributable to the parent company of 210 million yuan, a year-on-year decrease of 51.63%.
9 m ago
Guoketiancheng (301571.SZ) released its first three quarters performance, with net profit attributable to the parent company of 206 million yuan, a year-on-year increase of 63.53%.
10 m ago
Markets scale back bets on ECB rate hikes; cumulative hikes of 68 basis points expected by end-2027.
See all latest